Can a Slow Tapering and Therapy Help Stop Antidepressants Effectively?
Synopsis
Key Takeaways
- Gradual tapering of antidepressants is more effective than sudden cessation.
- Combining tapering with psychological support enhances recovery outcomes.
- Individualized treatment plans are essential for effective deprescribing.
- Evidence suggests that one in five individuals may prevent relapse using this method.
- Consultation with a healthcare provider is crucial before making changes to medication.
New Delhi, Dec 12 (NationPress) A gradual tapering of antidepressants combined with psychological support proves to be an effective approach for adults who have overcome depression to discontinue their medication, as revealed by a study released on Friday.
Typically, antidepressants are prescribed for a duration of six to nine months following an initial episode of moderate to severe depression and anxiety disorders to avert relapse.
However, there are rising concerns regarding overprescription, prolonged use, and withdrawal symptoms post-discontinuation, emphasizing the necessity for evidence-based deprescribing strategies.
To explore this issue, a team of researchers from the University of Verona in Italy undertook a systematic review and network meta-analysis encompassing 76 randomized controlled trials with a participant pool of 17,379 adults.
The study's results, published in The Lancet Psychiatry, do not imply that antidepressants are redundant or that psychotherapy alone suffices. On the contrary, it underscores the necessity of customizing deprescribing approaches for each individual, advocating for a gradual, individualized tapering of antidepressants along with structured psychological assistance.
“By integrating a substantially larger evidence base, a wider array of deprescribing strategies, and direct head-to-head comparisons, our new review clarifies the scientific understanding regarding the optimal method for discontinuing antidepressants for individuals successfully treated for depression and could reshape global practices in this regard,” stated lead author Professor Giovanni Ostuzzi from the University of Verona.
“We strongly advise anyone contemplating the cessation of antidepressants to consult their physician to collaboratively determine the most suitable strategy,” he added.
The researchers estimated that a slow tapering of antidepressants combined with psychological support could prevent one relapse in every five individuals compared to sudden cessation or fast tapering (the least effective methods), thus offering a clinically significant advantage.
Moreover, maintaining reduced doses of antidepressants also appeared more beneficial than abrupt stopping or fast tapering in minimizing relapse, although the evidence supporting this was less robust.
Interestingly, no significant disparities in reported side effects or dropout rates were observed among the different deprescribing strategies.